Algo version: 0.98b
Level Biotechnology Inc is listed at the TWO Exchange
Level Biotechnology Inc [3118.TWO]
TWO Sector: Healthcare Industry:Biotechnology

Is Level Biotechnology Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Level Biotechnology Inc pays dividends. Last time was Friday 12th of July 2024 where the investors holding the stock on Tuesday 18th of June 2024 were paid TWD1.7 per share. Over the last 16 times between 2009 and 2024, Level Biotechnology Inc has paid TWD27.17143 with an average of TWD1.7 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Level Biotechnology Inc 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD27.40, you would have made a profit of TWD4.55 per share or 16.61%

No, the average daily trading liquidity for Level Biotechnology Inc is TWD23 900 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Level Biotechnology Inc has no real debt, which is good in periods of high inflation. Level Biotechnology Inc has a good net profit margin of 9.14% and should have high tolerances against inflation.

We have calculated the inflation risk for Level Biotechnology Inc to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.